AAPL314.86-2.45 (-0.77%) ▼|ABBV244.78-3.22 (-1.30%) ▼|ABT88.96-3.15 (-3.42%) ▼|ACN134.56-3.96 (-2.86%) ▼|ADBE220.78-9.83 (-4.26%) ▼|AMAT595.70+20.31 (+3.53%) ▲|AMD548.13+13.74 (+2.57%) ▲|AMGN355.25-5.20 (-1.44%) ▼|AMT168.83-0.67 (-0.40%) ▼|AMZN247.49+0.18 (+0.07%) ▲|AVGO389.11+5.06 (+1.32%) ▲|AXP355.06+0.63 (+0.18%) ▲|BA217.11+1.60 (+0.74%) ▲|BAC60.62+1.12 (+1.88%) ▲|BKNG174.85-0.95 (-0.54%) ▼|BLK1,025.44-6.12 (-0.59%) ▼|BMY56.95-2.39 (-4.03%) ▼|BNY154.50+3.23 (+2.14%) ▲|BRK-B491.09-5.76 (-1.16%) ▼|C133.27-7.44 (-5.29%) ▼|CAT933.34+1.87 (+0.20%) ▲|CL91.03-2.18 (-2.34%) ▼|CMCSA23.19-0.78 (-3.25%) ▼|COF205.29+2.27 (+1.12%) ▲|COP111.87-0.98 (-0.87%) ▼|COST921.75-4.68 (-0.51%) ▼|CRM167.56-3.66 (-2.14%) ▼|CSCO117.09-2.16 (-1.81%) ▼|CVS106.18+0.28 (+0.26%) ▲|CVX181.76-0.44 (-0.24%) ▼|DE584.40-1.24 (-0.21%) ▼|DHR199.05-1.11 (-0.55%) ▼|DIS95.87-0.13 (-0.14%) ▼|DUK126.37-0.49 (-0.39%) ▼|EMR136.09+0.71 (+0.52%) ▲|FDX313.66-0.08 (-0.03%) ▼|GD369.50-3.28 (-0.88%) ▼|GE353.73+0.31 (+0.09%) ▲|GEV1,066.01+23.41 (+2.25%) ▲|GILD130.04-1.36 (-1.04%) ▼|GM76.87+0.15 (+0.20%) ▲|GOOG357.33+6.66 (+1.90%) ▲|GOOGL359.51+7.00 (+1.99%) ▲|GS1,140.00+94.09 (+9.00%) ▲|HD337.74+0.63 (+0.19%) ▲|HON222.68+0.43 (+0.19%) ▲|IBM217.07-73.16 (-25.21%) ▼|INTC107.76+4.64 (+4.50%) ▲|INTU282.43-7.33 (-2.53%) ▼|ISRG379.50-27.62 (-6.78%) ▼|JNJ253.85-3.92 (-1.52%) ▼|JPM342.89+8.36 (+2.50%) ▲|KO83.08-1.17 (-1.39%) ▼|LIN522.54-1.52 (-0.29%) ▼|LLY1,152.54-29.33 (-2.48%) ▼|LMT514.99-5.69 (-1.09%) ▼|LOW207.68-0.02 (-0.01%) ▼|LRCX346.10+16.18 (+4.90%) ▲|MA538.02+0.32 (+0.06%) ▲|MCD268.94-3.67 (-1.35%) ▼|MDLZ58.80-1.06 (-1.77%) ▼|MDT79.30-4.27 (-5.11%) ▼|META661.04+4.31 (+0.66%) ▲|MMM156.58-1.12 (-0.71%) ▼|MO70.16-1.71 (-2.38%) ▼|MRK120.78-3.25 (-2.62%) ▼|MS227.67+6.58 (+2.98%) ▲|MSFT384.93-6.06 (-1.55%) ▼|MU983.12+46.12 (+4.92%) ▲|NEE89.54+1.16 (+1.31%) ▲|NFLX73.53-0.30 (-0.41%) ▼|NKE42.86-0.90 (-2.06%) ▼|NOW104.85-6.41 (-5.76%) ▼|NVDA211.80+8.27 (+4.06%) ▲|ORCL127.94-3.60 (-2.74%) ▼|PEP135.45-3.04 (-2.20%) ▼|PFE24.25-0.23 (-0.94%) ▼|PG146.08-2.29 (-1.54%) ▼|PLTR133.72+3.68 (+2.83%) ▲|PM175.95-4.24 (-2.35%) ▼|QCOM178.10-5.88 (-3.20%) ▼|RTX193.39-3.00 (-1.53%) ▼|SBUX106.17-1.17 (-1.09%) ▼|SCHW101.10-1.28 (-1.25%) ▼|SO95.96-0.51 (-0.53%) ▼|SPG221.28+1.79 (+0.82%) ▲|T21.28-0.27 (-1.25%) ▼|TMO534.07+5.56 (+1.05%) ▲|TMUS187.13-1.28 (-0.68%) ▼|TSLA396.18+1.42 (+0.36%) ▲|TXN305.55+6.98 (+2.34%) ▲|UBER72.08-2.18 (-2.94%) ▼|UNH425.19-3.90 (-0.91%) ▼|UNP288.30-0.83 (-0.29%) ▼|UPS113.67+0.78 (+0.69%) ▲|USB62.14-0.20 (-0.32%) ▼|V356.02-1.73 (-0.48%) ▼|VZ42.47-0.21 (-0.49%) ▼|WFC85.29-2.38 (-2.71%) ▼|WMT113.70-1.08 (-0.94%) ▼|XOM145.09+0.58 (+0.40%) ▲|AAPL314.86-2.45 (-0.77%) ▼|ABBV244.78-3.22 (-1.30%) ▼|ABT88.96-3.15 (-3.42%) ▼|ACN134.56-3.96 (-2.86%) ▼|ADBE220.78-9.83 (-4.26%) ▼|AMAT595.70+20.31 (+3.53%) ▲|AMD548.13+13.74 (+2.57%) ▲|AMGN355.25-5.20 (-1.44%) ▼|AMT168.83-0.67 (-0.40%) ▼|AMZN247.49+0.18 (+0.07%) ▲|AVGO389.11+5.06 (+1.32%) ▲|AXP355.06+0.63 (+0.18%) ▲|BA217.11+1.60 (+0.74%) ▲|BAC60.62+1.12 (+1.88%) ▲|BKNG174.85-0.95 (-0.54%) ▼|BLK1,025.44-6.12 (-0.59%) ▼|BMY56.95-2.39 (-4.03%) ▼|BNY154.50+3.23 (+2.14%) ▲|BRK-B491.09-5.76 (-1.16%) ▼|C133.27-7.44 (-5.29%) ▼|CAT933.34+1.87 (+0.20%) ▲|CL91.03-2.18 (-2.34%) ▼|CMCSA23.19-0.78 (-3.25%) ▼|COF205.29+2.27 (+1.12%) ▲|COP111.87-0.98 (-0.87%) ▼|COST921.75-4.68 (-0.51%) ▼|CRM167.56-3.66 (-2.14%) ▼|CSCO117.09-2.16 (-1.81%) ▼|CVS106.18+0.28 (+0.26%) ▲|CVX181.76-0.44 (-0.24%) ▼|DE584.40-1.24 (-0.21%) ▼|DHR199.05-1.11 (-0.55%) ▼|DIS95.87-0.13 (-0.14%) ▼|DUK126.37-0.49 (-0.39%) ▼|EMR136.09+0.71 (+0.52%) ▲|FDX313.66-0.08 (-0.03%) ▼|GD369.50-3.28 (-0.88%) ▼|GE353.73+0.31 (+0.09%) ▲|GEV1,066.01+23.41 (+2.25%) ▲|GILD130.04-1.36 (-1.04%) ▼|GM76.87+0.15 (+0.20%) ▲|GOOG357.33+6.66 (+1.90%) ▲|GOOGL359.51+7.00 (+1.99%) ▲|GS1,140.00+94.09 (+9.00%) ▲|HD337.74+0.63 (+0.19%) ▲|HON222.68+0.43 (+0.19%) ▲|IBM217.07-73.16 (-25.21%) ▼|INTC107.76+4.64 (+4.50%) ▲|INTU282.43-7.33 (-2.53%) ▼|ISRG379.50-27.62 (-6.78%) ▼|JNJ253.85-3.92 (-1.52%) ▼|JPM342.89+8.36 (+2.50%) ▲|KO83.08-1.17 (-1.39%) ▼|LIN522.54-1.52 (-0.29%) ▼|LLY1,152.54-29.33 (-2.48%) ▼|LMT514.99-5.69 (-1.09%) ▼|LOW207.68-0.02 (-0.01%) ▼|LRCX346.10+16.18 (+4.90%) ▲|MA538.02+0.32 (+0.06%) ▲|MCD268.94-3.67 (-1.35%) ▼|MDLZ58.80-1.06 (-1.77%) ▼|MDT79.30-4.27 (-5.11%) ▼|META661.04+4.31 (+0.66%) ▲|MMM156.58-1.12 (-0.71%) ▼|MO70.16-1.71 (-2.38%) ▼|MRK120.78-3.25 (-2.62%) ▼|MS227.67+6.58 (+2.98%) ▲|MSFT384.93-6.06 (-1.55%) ▼|MU983.12+46.12 (+4.92%) ▲|NEE89.54+1.16 (+1.31%) ▲|NFLX73.53-0.30 (-0.41%) ▼|NKE42.86-0.90 (-2.06%) ▼|NOW104.85-6.41 (-5.76%) ▼|NVDA211.80+8.27 (+4.06%) ▲|ORCL127.94-3.60 (-2.74%) ▼|PEP135.45-3.04 (-2.20%) ▼|PFE24.25-0.23 (-0.94%) ▼|PG146.08-2.29 (-1.54%) ▼|PLTR133.72+3.68 (+2.83%) ▲|PM175.95-4.24 (-2.35%) ▼|QCOM178.10-5.88 (-3.20%) ▼|RTX193.39-3.00 (-1.53%) ▼|SBUX106.17-1.17 (-1.09%) ▼|SCHW101.10-1.28 (-1.25%) ▼|SO95.96-0.51 (-0.53%) ▼|SPG221.28+1.79 (+0.82%) ▲|T21.28-0.27 (-1.25%) ▼|TMO534.07+5.56 (+1.05%) ▲|TMUS187.13-1.28 (-0.68%) ▼|TSLA396.18+1.42 (+0.36%) ▲|TXN305.55+6.98 (+2.34%) ▲|UBER72.08-2.18 (-2.94%) ▼|UNH425.19-3.90 (-0.91%) ▼|UNP288.30-0.83 (-0.29%) ▼|UPS113.67+0.78 (+0.69%) ▲|USB62.14-0.20 (-0.32%) ▼|V356.02-1.73 (-0.48%) ▼|VZ42.47-0.21 (-0.49%) ▼|WFC85.29-2.38 (-2.71%) ▼|WMT113.70-1.08 (-0.94%) ▼|XOM145.09+0.58 (+0.40%) ▲|
32.2 C
New York
Wednesday, July 15, 2026

Tag: services

newssourceFORcompanyinformationcontent1releasesmarket

Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management. 
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

Find Mining Launches One-Stop AI Cloud Mining for Sustainable Digital Wealth

As Bitcoin returns to the $100,000 mark and global demand for clean energy and remote computing services continues to grow, Find Mining, a long-established cloud mining platform founded in 2018, announced that it has officially launched a new one-stop multi-currency AI cloud mining solution and supporting mobile applications, committed to providing global users with a smarter, low-threshold, and sustainable way to increase the value of digital assets. 
As Bitcoin returns to the $100,000 mark and global demand for clean energy and remote computing services continues to grow, Find Mining, a long-established cloud mining platform founded in 2018, announced that it has officially launched a new one-stop multi-currency AI cloud mining solution and supporting mobile applications, committed to providing global users with a smarter, low-threshold, and sustainable way to increase the value of digital assets.

Shareholder Alert: Johnson Fistel, LLP Investigates Elanco Animal Health, Masimo, Fidelity National Information, and Super Micro Computer —Long-Term Investors are Encouraged to Contact the...

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, is investigating potential violations of federal and state laws by officers and directors of Elanco Animal Health Incorporated (NYSE: ELAN), Masimo Corporation (NASDAQ: MASI), Fidelity National Information Services, Inc. (NYSE: FIS), and Super Micro Computer, Inc. (NASDAQ: SMCI).

Cascadia Announces Closing of Financing

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, July 3, 2025 /CNW/ - Cascadia Minerals Ltd. ("Cascadia")...

Red White & Bloom Brands Provides Update on Status of Annual Filings

TORONTO, July 03, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) provides the following update regarding the management cease trade order (“MCTO”) issued by the British Columbia Securities Commission (“BCSC”) on May 1, 2025, under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).

BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS

-Record earnings increasing to $0.19 per share -Record operating income of $16.8 million, reflecting a 27% increase from prior year OLATHE, Kan., July 3, 2025 /PRNewswire/...

March of Dimes Statement on the Passage of H.R. 1

ARLINGTON, Va., July 3, 2025 /PRNewswire-HISPANIC PR WIRE/ -- The passage of H.R. 1, the "One Big Beautiful Bill Act," sets in motion harmful...

Texas Capital Bancshares, Inc. Announces Date for Q2 2025 Operating Results

DALLAS, July 03, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the second quarter of 2025 before market on Thursday, July 17, 2025. Executive management will host a conference call and webcast to discuss second quarter 2025 operating results on Thursday, July 17, 2025, at 9:00 a.m. EDT.

Neuro Balance Therapy Update: Strongest Non-Clinical Reflex Routine for Seniors Concerned About Instability

New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+ 
New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+

March of Dimes Statement on the Passage of H.R. 1

ARLINGTON, Va., July 3, 2025 /PRNewswire/ -- The passage of H.R. 1, the "One Big Beautiful Bill Act," sets in motion harmful changes to...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

Westhaven Closes Non-Brokered Private Placement with Eric Sprott and Earthlabs, for Gross Proceeds of $3.16 Million

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support

Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness 
Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsServices

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers